Nakajima H, Ito K. An example of anti-Jra causing hemolytic disease of the newborn and frequency of Jra antigen in the Japanese population. Vox Sang 1978;35:265-7.Search in Google Scholar
Reid ME, Lomas-Francis C. Blood group antigen factsbook. 2nd ed. San Diego: Academic Press, 2003.10.1016/B978-012586585-2/50007-XSearch in Google Scholar
Azar PM, Kitagawa H, Fukunishi A, et al. Uneventful transfusion of Jr (a+) red cells in the presence of anti-Jra. Jpn J Transfus Med 1988;34:406-10.10.3925/jjtc1958.34.406Search in Google Scholar
Bacon J, Sherrin D, Wright RG. Case report, anti-Jra. Transfusion 1986;26:543-4.10.1046/j.1537-2995.1986.26687043624.xSearch in Google Scholar
Schanfield MS, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantibodies, using a human mononuclear phagocyte assay. Transfusion 1981;21:571-6.10.1046/j.1537-2995.1981.21582040822.xSearch in Google Scholar
Kwon MY, Su L, Arndt PA, Garratty G, Blackall DP. Clinical significance of anti-Jra: report of two cases and review of the literature. Transfusion 2004;44: 197-201.10.1111/j.1537-2995.2004.00643.xSearch in Google Scholar
Yoshida H, Yurugi K, Ito K. A case of delayed hemolytic transfusion reaction due to anti-Jra. Jpn J Tranfus Med 1991;34:528-30.Search in Google Scholar
Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273-81.10.1111/j.1537-2995.2004.03427.xSearch in Google Scholar
Takabayashi T, Murakami M, Yajima H, Tsujiei M, Ozawa N, Yajima A. Influence of maternal antibody anti-Jra on the baby: a case report and pedigree chart. Tohoku J Exp Med 1985 Jan;145(1):97-101.10.1620/tjem.145.97Search in Google Scholar
Orrick LR, Golde SH. Jra mediated hemolytic disease of the newborn infant. Am J Obstet Gynecol 1980;137:135-6.10.1016/0002-9378(80)90397-XSearch in Google Scholar
Toy P, Reid M, Lewis T, Ellisor S, Avoy DR. Does anti-Jra cause hemolytic disease of the newborn? Vox Sang 1981;41(1):40-4.10.1111/j.1423-0410.1981.tb01010.x7324442Search in Google Scholar
Kendall AG. Clinical importance of the rare erythrocyte antibody anti-Jra. Transfusion 1976;16:646-7.10.1046/j.1537-2995.1976.16677060250.x996925Search in Google Scholar
Jowitt S, Powell H, Shwe KH, Love EM. Transfusion reaction due to anti-Jra (abstract). Transfus Med 1994;4(suppl 1):49.Search in Google Scholar
Ogasawara K, Mazuda T. Characterization of Jra antibodies by monocyte phagocytosis assays and flow cytometry analysis. Acta Haematol Jpn (in Jap) 1990;53:1131-7.Search in Google Scholar
Garratty G, Arndt P, Nance S. The potential clinical significance of blood group alloantibodies to high frequency antigens (abstract). Blood 1997; 10(suppl 1):473a.Search in Google Scholar
Miyazaki T, Kwon K, Yamamoto K, et al. A human monoclonal antibody to high-frequency red cell antigen Jra. Vox Sang 1994;66:51-4.10.1111/j.1423-0410.1994.tb00277.x8146983Search in Google Scholar
National Blood Service. Guidance for the selection of blood for patients with common and rare red cell antibodies. Blood Matters 2003;13. Available at http://www.blood.co.uk/hospitals/library/bm/iss ue13/BM1303.htm. Posted August 13, 2003.Search in Google Scholar
